Cred Opens Its Platform to Developers and Businesses
10.12.2018 23:21:00 EET | Business Wire | Press release
Cred, the leading provider of crypto-backed lending with over $300 million in credit facilities, today announced the launch of CredX, Cred’s developer platform, enabling any company or developer to turn their products into powerful financial applications for their customers. Crypto exchanges, crypto wallets, miner service providers, even traditional financial institutions have the ability to access Crypto Lending as a Service (CLaaS™) and create a rich set of customer experiences for their customers.
“Lending and Earning Crypto are hard businesses to get right, particularly in a bear market,” said Dan Schatt, Co-Founder of Cred and the Universal Protocol Alliance. “A crypto custodian, wallet, merchant or exchange business can now offer their customers compelling credit and treasury management features built directly into their own apps, powered by Cred. Businesses can choose to use their own balance sheets, or leverage Cred’s to provide credit and earning services to generate revenue, customer retention, cost saves and receive an instant settlement. Companies can also place their BTC with Cred to earn substantial interest. We look forward to continually adding new functionality that will appeal to new and existing customers of crypto. Even traditional financial institutions can benefit.”
Cred’s APIs will allow businesses of every size affordable access to low-interest loans using crypto as collateral. The platform provides the simplicity and reliability needed to navigate the complexity of blockchain financial services. Some of the companies currently building CredX services and LBA token utility in their applications include:
Uphold – Uphold has over 1 million users around the world and has traded over $4.1 billion on its digital money platform and reserve ledger. Uphold customers will be able to borrow dollars against their crypto and earn returns on their stablecoins via Uphold Borrow and Uphold Earn powered by Cred.
Acre - Acre is a crypto investment application that enables micro-investing in cryptocurrencies. Acre demystifies and democratizes the cryptocurrency space, making the value of crypto projects accessible to everyday people. Acre’s customers will be able to collateralize their crypto to access low-interest rate loans and earn a return on their tokens.
Heleum: Heleum is a financial software company that has developed investment applications that automate the process of buying, selling and trading crypto and fiat pairs. Heleum will leverage the CredX platform where funds borrowed through Cred can be invested automatically through Heleum and allow users who stake their LBA to earn returns that can offset their loan interest and principal.
“Cred is creating the next generation of platform APIs for the crypto community, something that venerable companies such as PayPal and Stripe are not providing today,” said Scott Thompson, Former President of PayPal. “The future of financial services require a more open and transparent approach to FinTech, and Cred’s former PayPal team is well positioned to meet a market need.”
“I’ve always felt that distributed ledgers are a natural outcome of social media, blockchain and open source,” said Brett King, Author of Bank 4.0 and Co-Founder and CEO of Moven Bank. “Happy to see that lending and earning are emerging as an excellent set of application services on the CredX platform.”
“The CredX platform enables our company to build some products that are very exciting for our customers-- automated margin trading of fiat and crypto pairs, the ability to lower interest rates through LBA staking and the potential to generate income to pay back loans,” said Pace Ellsworth, Co-Founder, and CEO of Heleum. “We look forward to building many more future products with CredX.”
“We’ve been big fans of Cred from day one and foresee a huge opportunity to increase yields on crypto and fiat, and lower the cost of loans to Uphold customers in 180+ countries,” said JP Thieriot, Co-founder and CEO of Uphold. “Everyone wins when we can combine Cred’s best of breed credit and treasury management capabilities with Uphold’s crypto and fiat banking and investment services.”
“We believe crypto as an asset class will outperform traditional assets over the next 10 years, and our ability to tap into Cred’s platform to provide a combination of saving and investment features will provide more financial freedom and flexibility for our customers,” said Brendon McQueen, Co-Founder, and CEO of Acre.
For more information, visit CredX or email developer@mycred.io
About Cred:
Cred is a decentralized global lending platform that facilitates open access to credit anywhere and anytime. Founded by former PayPal financial technology veterans, Cred has secured over $300,000,000 of global lending capital. Cred’s mission is to harness the power of blockchain to allow everyone to benefit from low-cost credit products. Cred brings together a diverse team of entrepreneurial leaders, machine learning, and the power of blockchain technology. For more information, visit mycred.io or follow us on Twitter, LinkedIn, or join our community on Telegram.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181210005787/en/
Contact information
Meghan Gardler
Cred, Director of Marketing
meghan@mycred.io
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
